Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis

Medicin og biovidenskab

• lactitol 100%
• Lactulose 77%
• Disaccharides 74%
• Hepatic Encephalopathy 68%
• Fibrosis 42%
• Placebos 39%
• Randomized Controlled Trials 38%
• Odds Ratio 13%
• Confidence Intervals 12%
• Therapeutics 9%
• Meta-Analysis 9%
• Risk Reduction Behavior 8%
• Mortality 6%
• Hepatorenal Syndrome 5%
• Research Personnel 5%
• Quality of Life 5%
• Bibliographies 4%
• Non-Randomized Controlled Trials 4%
• Publication Bias 4%
• Liver Failure 4%
• Congresses 4%
• MEDLINE 3%
• Liver Diseases 3%
• Publications 3%
• Language 3%
• Data Analysis 3%
• Regression Analysis 2%
• Health Care Outcome Assessment 2%
• Hemorrhage 2%
• Pharmaceutical Preparations 1%